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Background: Human bocavirus (HBoV) is a newly identified viral pathogen, and its clinical epidemiology and significance in respi-
ratory infections have not yet been completely elucidated. We investigated the prevalence of HBoV infection and the association 
between viral (HBoV) load and clinical features of the infection in patients of all age-groups. 
Methods: Nasopharyngeal aspirates from patients with symptoms of respiratory infection were tested for presence of HBoV by us-
ing real-time polymerase chain reaction. HBoV-positive patients were categorized into low– and high–viral-load groups using 1.0× 
10
6 copies/mL as the threshold value of viral load.
Results: Detection rate of HBoV was 4.8% (N=93) in a total of 1,926 samples with peak incidence of infection being observed in 
patients aged 6–12 months. HBoV infection was more frequently observed in young children, especially, in children aged less than 
5 yr, and the HBoV load decreased with increase in age. HBoV was codetected with other respiratory viruses in 17 (18.3%) of the 93 
HBoV-positive patients and 15 patients (88.2%) belonged to the low–viral-load group. Patients infected with HBoV alone showed a 
higher viral load than those patients in whom HBoV was codetected with other respiratory viruses (median load, 3.78× 10
5 copies/
mL vs. 1.94×10
4 copies/mL, P=0.014). Higher pulse rate (P=0.007) and respiratory rate (P=0.021) were observed in patients with a 
high–viral-load.
Conclusions: Our results suggest that HBoV may be the causative agent of respiratory infection in the high–viral-load group.
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INTRODUCTION
Human bocavirus (HBoV) was newly discovered by Al-
lander et al. [1] and was stated to be the possible causative 
agent of respiratory illness. Phylogenetic analysis of the 
complete genome of HBoV revealed that the virus is most 
closely related to canine minute virus and bovine parvovi-
rus, which are members of the Bocavirus genus of the Par-
voviridae family [1].
HBoV was found in 1.5-11.3% of respiratory samples in-
vestigated worldwide [2-5]. HBoV may be a causative agent 
of respiratory tract infections. However, some investigators 
argue that the association between HBoV and respiratory 
tract diseases remains unproven because of the high rate of 
codetection of HBoV with other respiratory pathogens [5]. 
Its clinical epidemiology and role in respiratory infection 
have not yet been fully elucidated.
Although recently it was found that HBoV could be cul-
tured in differentiated human airway epithelial cells [6], 
routine viral culturing of HBoV remains difficult. Real-time 
PCR has been used to estimate viral load and its usefulness 
has been proved as an indicator of the degree of active viral 
infection, interactions between the virus and the host, and 
the role of viral reactivation or persistence in the progres-
sion of disease [7]. In this study, we investigated the epide-
miology of HBoV and the clinical features of respiratory in-
fection associated with HBoV, especially in terms of HBoV 
load. 
 
MATERIALS AND METHODS
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from 1,815 patients were randomly selected among the 5,891 
samples collected from patients referred to the Korea Uni-
versity Guro Hospital for screening for respiratory viruses. 
Among the patients, 59.0% were men, and the ages of the 
patients ranged from 1 day to 86.0 yr (mean=6.1 yr, me-
dian=26 months); children aged 5 yr or less constituted 
75.3% of the study population. The nasopharyngeal aspirates 
(NPAs) obtained from all patients were stored in a viral 
transport medium and quickly delivered to the laboratory 
by using wet ice. R-Mix culture system (Diagnostic HY-
BRIDS, Athens, OH, USA) was used to screen the samples 
for presence of 5 respiratory viruses (influenza A and B vi-
ruses, parainfluenza viruses, respiratory syncytial virus, and 
adenovirus). 
2. Methods
1) Conventional PCR
Total nucleic acid was extracted from 100 µL of the sam-
ple by using Instagene Matrix Kit (Bio-Rad, Hercules, CA, 
USA). PCR primers were designed using Beacon Designer 
software (Premier Biosoft International, Palo Alto, CA, 
USA) in the conserved region of the NS-1 coding region of 
the HBoV genome by using the HBoV ST2 sequence (Gen-
bank accession number: DQ000496). The forward primer 
(5´-GCAAATCTCTTCTGGCTACACG-3´) and the re-
verse primer (5´-CCTCTGCGATCTCTATATTGAAGG- 
3´) were targeted at a portion of the HBoV NS-1 gene. The 
conventional PCR reaction mixture consisted of 0.2 pg/μL 
forward and reverse primers, 2.5 mM dNTPs, 50 mM KCl, 
1.5 mM MgCl2, 5 U of Taq polymerase, and 3 μL of extract-
ed DNA in a final volume of 25 μL. The PCR cycling condi-
tions consisted of 35 cycles (involving reaction at 30 sec at 
94˚C, 30 sec at 60˚C, and 30 sec at 72˚C) after the preheat-
ing step of 3 min at 94˚C. All the PCR products obtained 
from positive reactions were sequenced completely to con-
firm sequence specificity.
2) Plasmid standard construction
To obtain standard curves for absolute quantification, the 
PCR product of HBoV was cloned into a plasmid vector 
pGEM®-T Easy Vector (Promega, Madison, WI, USA), pu-
rified using a QIAprep mini prep kit (Qiagen Inc., Valencia, 
CA, USA), and quantified using UV spectroscopy (1 geno-
mic copy=5×10
-12 µg). Serial 10-fold dilutions of the clon-
ed plasmid were prepared to generate the standard curves. 
3) Real-time PCR
Real-time PCR for viral load was performed on the speci-
mens positive for HBoV by conventional PCR. A TaqMan 
probe (5´-ATGTTGCCGCCAGTAACTCCACCC-3´) was 
labeled at the 5´ ends with the reporter molecule FAM and 
at the 3´ ends with Black Hole Quencher 1 (Biosearch Tech-
nologies, Inc., Novato, CA, USA). The assay was performed 
using Rotor-Gene 6000 (Corbett Life Science, Sydney, Aus-
tralia) and the standard protocol of TaqMan universal PCR 
master mix (Applied Biosystems, Foster City, CA, USA); 
each 25 µL sample of the reaction mixture contained 10 pg/
µL of the forward and the reverse primers and 3 µL of the 
extracted DNA. Amplification conditions consisted of reac-
tions for 3 min at 50˚C, 3 min at 94˚C, and 40 cycles of 30 
sec at 94˚C, 30 sec at 60˚C and 30 sec at 72˚C maintained 
for 3 min. Detection limit of real-time PCR for HBoV was 
1.3×10
3 copies/mL, which corresponded to 33 copies per 
reaction.
3. Statistical analysis
Statistical analysis was performed using the SPSS software 
(version 10, SPSS Inc., Chicago, IL, USA), and graphs were 
prepared using Prism software (version 4.0, GraPad Soft-
ware, Inc., San Diego, CA, USA). Mann-Whitney U test, 
Chi-squared or Fisher’s exact test were performed to assess 
the significance. A P value <0.05 was considered statisti-
cally significant for all the tests. 
RESULTS
A total of 1,926 samples of patients with respiratory sym-
ptoms were included in the present study. Ninety-three (4. 
8%) samples were found to be positive for HBoV by PCR 
and subsequent sequencing. Other respiratory viruses de-
tected during the study period were as follows: influenza A 
virus (IFA), 56 patients (2.9%); influenza B virus (IFB), 50 
patients (2.6%); parainfluenza viruses (PIV), 142 patients 
(7.4%); respiratory syncytial virus (RSV), 97 patients (5.0%); 
and adenovirus (ADV), 40 patients (2.1%). HBoV was more 
prevalent in men (73.1%) than in women (P=0.005). 
HBoV was detected in patients ranging from 3 months to 
65.6 yr (mean=36.2 months, median=19 months) with a 
peak prevalence between the ages of 6 and 12 months (8. 
6%, 22/257). Children aged 5 yr or less constituted 92.5% 
(86/93) of the HBoV-positive patients (Table 1). 
HBoV was detected in the samples obtained throughout 
the course of the study with the detection rate being the 
highest in June (16/129, 12.4%), followed by August (9/110, 
8.2%) and May (13/162, 8.0%). From April to June 2006, 
43% of the HBoV-positive cases were observed (Fig. 1). 
All the 93 HBoV-positive cases detected by conventional 
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ing the TaqMan probe. The viral load detected in the HBoV-
positive samples by using real-time PCR was in the range of 
1.3×10
3-4.6×10
9 copies/mL (median, 1.82×10
5 copies/
mL). The HBoV-positive cases were categorized in 2 groups: 
low-viral-load group (viral load ≤1.0×10
6 copies/mL, N= 
58) and high-viral-load group (viral load >1.0×10
6 copies/
mL, N=35) (Table 1). The HBoV-positive patients aged less 
than 3 yr had a significantly higher viral load than that in 
the patients aged more than 3 yr (P=0. 001). 
The other respiratory viruses found in 17 (18.3%) of the 
total HBoV-positive samples were as follows: IFA, 1 sample; 
IFB, 1 sample; PIV, 10 samples; RSV, 4 samples; and ADV, 1 
sample. Most of the cases (88.2%, 15/17) belonged to the 
low-viral-load group. RSV was isolated from the remaining 
2 samples with HBoV copy numbers of 1.09×10
6 copies/
mL and 2.65×10
8 copies/mL. 
Patients positive for HBoV alone had a higher viral load 
than that in the patients who were positive for both HBoV 
and another respiratory virus (median 3.78×10
5 copies/mL 
vs. 1.94×10
4 copies/mL, P=0.014). A high-viral-load was 
almost exclusively seen in the HBoV-positive patients alone 
(94.3%, 33/35) (Fig. 2).
The high-viral-load group had a significantly higher pulse 
rate and respiratory rate than the corresponding rates in the 
low-viral-load group (P=0.007 and P=0.0231, respectively; 
Table 2). Although the duration of hospital stay was not sig-
nificantly different between the 2 groups (Table 2), in cases 
of patients with less than 10 days of hospital stay, the high-
viral-load group had a longer hospital stay than the low-vi-
ral-load group did (5.2±1.5 days vs. 4.1±1.4 days, P=0. 
009). Most of the other clinical characteristics had no sig-
nificant correlation with the viral load of HBoV. The HBoV-
positive patients presented with cough (80.6%), sputum 
(63.4%), fever (62.4%), rhinorrhea (50.5%), crackle (44.1%), 
wheezing (33.3%), diarrhea (14.0%), and dyspnea (6.5%). 
No significant difference was observed in the HBoV viral 
loads in the cases of upper and lower respiratory tract infec-
tions (P=0.077). Twenty-one out of 26 patients with under-
lying conditions had low-viral-loads.
Clinical examination of the HBoV-positive patients show-
ed pneumonia, bronchiolitis, bronchitis, croup, asthma, si-
nusitis, and pharyngotonsilitis (Fig. 3). HBoV was detected 
in 8.4% (N=48) and 5.6% (N=45) of the samples obtained 
from patients with and without pneumonia, respectively 
(N=572 and 805, respectively; P=0.049). However, no sig-
nificant difference was observed in the viral load between 
Table 1. Age distribution of human bocavirus-positive patients
Age
N (%) of human bocavirus-positive patients
Total Low-viral-load group* High-viral-load group*
0-6 mon (N=291) 3 (1.0) 2 (0.7) 1 (0.3)
6-12 mon (N=257) 22 (8.6) 12 (4.7) 10 (3.9)
1-2 yr (N=368) 31 (8.4) 15 (4.1) 16 (4.3)
2-3 yr (N=246) 15 (6.1) 9 (3.7) 6 (2.4)
3-5 yr (N=289) 15 (5.2) 13 (4.5) 2 (0.7)
5-10 yr (N=271) 5 (1.8) 5 (1.8) 0
10-15 yr (N=61) 0 0 0
> 15 yr (N=143) 2 (1.4) 2 (1.4) 0
Total (N=1,926) 93 (4.8) 58 (3.0) 35 (1.8)
*Human bocavirus positive patients were grouped into low-and high-viral-load 
groups using 1.0×10
6 copies/mL as the threshold value. 
Fig. 2. HBoV viral load distribution of cases with HBoV infection alone and of 
cases in which HBoV was codetected with other viruses. The dotted line indi-
cates the cut-off between the high-and the low-viral-load groups. The dashed 
lines indicate the median of each group. 
Abbreviation: HBoV, human bocavirus.
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the patients with and without pneumonia (P>0.05).
 DISCUSSION
Ninety-three (4.8%) of the 1,926 nasopharyngeal aspi-
rates obtained from patients of all age-groups were positive 
for HBoV. Our detection rate is similar to that stated in 
other reports [2, 3, 8]. Generally, HBoV is detected in fewer 
than 8% of respiratory specimens [1, 8-13]; however, higher 
detection rates ranging from 10.3% to 19% have been re-
ported [5, 14, 15]. 
To investigate the epidemiological association of respira-
tory infection with viral load, HBoV-positive patients were 
categorized into low- and high-viral-load groups by using 
1.0×10
6 copies/mL as a threshold value. The detection rate 
of HBoV infection was at its peak in the first year of life (rate 
of detection, 8.6% between the ages of 6 and 12 months), as 
in the cases of RSV or PIV infection. Most of the HBoV-
positive patients aged less than 3 yr belonged to the high-vi-
ral-load group. The detection rate was lower (1.5%) in pa-
tients aged more than 10 yr, and these patients belonged ex-
clusively to the low-viral-load group. HBoV is rarely de-
tected in adults except in cases of immunosuppression [10, 
16, 17]. The lower detection rate and viral load of HBoV in 
older patients may be attributed to immunity acquired from 
an infection at a younger age. A seroepidemiologic study of 
HBoV showed that 5.6-83.3% of children aged 6 months-3 
yr were seropositive for HBoV [18]. Lau et al. [19] suggest-
ed that HBoV infection might develop only once because of 
the subsequent development of life-long immunity conferr-
ed by neutralizing antibodies produced in response to the 
infection. 
The frequency of HBoV codetection with other respira-
tory viruses was 18.3% in the HBoV-positive samples and 
was lower than the previously published data [4, 20]. This 
difference in the codetection frequency is attributed to the 
different detection methods; molecular diagnostic methods 
were used for the detection of other respiratory viruses in 
the other studies whereas we used virus culturing. Among 
the 17 HBoV-positive patients who were also positive for 
infection with other viruses, 10 showed PIV infection. The 
high association of HBoV with PIV seems to be attributed 
to the high prevalence of PIV infection in 2006 (22.8% in 
May). Interestingly, almost all cases (except two) positive 
for both HBoV and another respiratory virus belonged to 
the low-viral-load group. As the virus culture was used for 
the detection of major respiratory viruses, the isolated virus 
could be the main causative agent of respiratory illness. 
Therefore, the presence of low copy number of HBoV, de-
tected by molecular method, may indicate prolonged viral 
shedding or an asymptomatic infection. Recently, pro-
longed presence of HBoV in NPAs has been reported [21]. 
These results suggest that single HBoV infection in the 
high-viral-load group may play an active role in respiratory 
infection. These findings are consistent with a Norwegian 
study that reported detection of HBoV alone and a high-vi-
Table 2. Comparison of demographic and clinical characteristics of patients 
hospitalized for human bocavirus infection on the basis of viral loads*
Low-viral-load 
group (N=58)
High-viral-load 
group (N=35) P value
Duration of symptoms before 
admission (days)
5.4±6.5 4.7±4.4 0.586
Duration of hospitalization (days) 5.6±3.0 6.5±3.0 0.146
Pulse rate (/min) 121.3±16.4 131.5±18.5 0.007
Respiratory rate (/min) 28.2±6.0 31.9±9.8 0.023
WBC (×10
9 cells/mL) 1.1±5.8 1.3±5.6 0.093
ESR (mm/sec) 29.1±21.1 29.9±28.9 0.879
C-reactive protein (mg/L) 15.6±40.9 11.2±25.1 0.574
Fever 38 (65.5) 20 (57.1) 0.509
Cough 42 (72.4) 33 (94.3) 0.013
Dyspnea 3 (5.2) 3 (8.6) 0.669
Sputum 32 (55.2) 27 (77.1) 0.045
Rhinorrhea 29 (50.0) 18 (51.4) 1.000
Diarrhea 10 (17.2) 3 (8.6) 0.357
Abdominal pain 22 (37.9) 16 (45.7) 0.517
Rale 3 (5.2) 1 (2.9) 1.000
Wheezing 17 (29.3) 14 (40.0) 0.365
Crackle 26 (44.8) 15 (42.9) 1.000
Underlying conditions 21 (80.8) 5 (19.2) <0.001
Abnormality on chest radiograph 26 (44.8) 12 (34.3) 0.386
*Data presented as mean±standard deviation or number (%) of patients.
Abbreviations: WBC, white blood cell; ESR, erythrocyte sedimentation rate.
Fig. 3. Distribution of viral load in HBoV-positive patients according to dis-
eases.
Abbreviation: HBoV, human bocavirus.
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ral-load were associated with respiratory tract infection 
[20]. In that study, patients with a high-viral-load in NPAs 
developed viremia more frequently than the patients with a 
moderate-or a low-viral-load did. In our study, HBoV-posi-
tive patients in the high-viral-load group showed signifi-
cantly higher pulse rates and respiratory rates than the in 
the low-viral-load group. These findings also support the 
idea that a high-viral-load may be associated with a respira-
tory infection.
Previous studies have reported that HBoV infection was 
more prevalent among individuals who had other respira-
tory viruses [10, 22]. In a study performed in Hong Kong 
[19], a higher detection rate of HBoV was observed in NPAs 
positive for common respiratory viruses than in those that 
were negative for the same. However, in our study, similar 
detection rate of HBoV was observed in the samples posi-
tive and negative for other respiratory viruses in the R-mix 
culture (Data are not shown). 
Previous studies showed that cases of HBoV infection 
were found throughout the year with a peak incidence rate 
in the winter season [10, 13, 23]. However, in our study, 
cases of HBoV infection were detected most frequently dur-
ing the spring season. This finding is similar to those of re-
ports from Korea [4, 24]. This seasonal difference in the in-
cidence of HBoV infection may be attributed to regional and 
temporal differences.
Bastien et al. [8] suggested that risk factors for severe 
HBoV infection appear to be similar to those for RSV infec-
tion (prematurity, congenital heart disease, and asthma). 
Thirty percent (26/93) of the HBoV-positive patients had 
underlying conditions such as heart disease, asthma, allergy, 
preterm birth, and a history of convulsions; most of these 
patients (80.8%) showed a low-viral-load. Persistent HBoV 
shedding for more than 1 month is observed in both respi-
ratory and fecal specimens obtained from patients with sig-
nificant underlying diseases [19]. Although these finding 
were not fully understood, it is postulated to be a result of 
underlying immunosuppression [19].
In summary, HBoV infection was more prevalent in yo-
ung children. Patients positive for HBoV alone mainly con-
stituted the high-viral-load group. Most of the HBoV-posi-
tive patients with infection caused by other respiratory vi-
ruses belonged to the low-viral-load group. These findings 
suggest that HBoV may be associated with a respiratory in-
fection. 
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